Company Profile
Avalo Therapeutics Stock Price, News & Analysis
- Ticker:
- AVTX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
19.50 USD (+5.75%)
Close
Last updated: July 27, 2026
734M USD
Market cap
Why the stock is moving
As of Jul 27, 2026, AVTX closed up 5.75% at $19.50. No new same-company headline was identified in the current news window.
Company overview
Business overview
Avalo Therapeutics is a biotechnology company focused on immune-mediated and inflammatory diseases. Its pipeline aims at selective immune pathways and niche inflammation opportunities.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Avalo sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical validation, target selection, and the ability to create a durable immunology story.
Position Within the Biotechnology Landscape
Avalo is a catalyst-sensitive immunology name whose stock is tied to early data and strategy.
Future catalysts
The cleaner way to frame Avalo Therapeutics right now is around its latest development priorities. The most useful line from the latest update is the next company-specific pipeline update. That should keep the program at the center of the company narrative for now.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Kymera Therapeutics Appoints Terence Rooney, MD, as Chief Medical Officer
KYMR · Source: Kymera
- 02
- 03
- 04
- 05
Avalo Therapeutics to Participate in the BTIG Biotechnology Conference
Source: Avalo Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Avalo Therapeutics (AVTX)?
Avalo Therapeutics (AVTX) most recently closed at 19.50 USD, a +5.75% move versus the previous session.
What is the market cap of Avalo Therapeutics (AVTX)?
Avalo Therapeutics currently has a market capitalization of 734M USD on BioPharmSignal.
What does Avalo Therapeutics do?
Avalo Therapeutics is a biotechnology company focused on immune-mediated and inflammatory diseases. Its pipeline aims at selective immune pathways and niche inflammation opportunities.
On which exchange is AVTX stock listed?
Avalo Therapeutics (AVTX) is associated with NASDAQ, United States, Biopharma.
What is Avalo?
The cleaner way to frame Avalo Therapeutics right now is around its latest development priorities.
Which conditions is Avalo Therapeutics targeting with Avalo?
Avalo Therapeutics is associated with inflammatory disease based on its company overview and current catalyst commentary.
How does Avalo Therapeutics describe recent progress with Avalo?
The cleaner way to frame Avalo Therapeutics right now is around its latest development priorities.
What is Therapeutics?
Avalo Therapeutics is a biotechnology company focused on immune-mediated and inflammatory diseases.